Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation

Figure 1 Kaplan–Meier analysis. A: Waitlist dropout due to tumor progression according to locoregional therapy performed. Log-rank test for the comparison between the two groups: P = 0.29; B: Post-transplant recurrence-free survival according to locoregional therapy performed. Log-rank test for the comparison between the two groups: P log-rank test = 0.71. TACE: Transarterial chemoembolization; TAE: Transarterial embolization; LRT: Locoregional therapy; OLT: Orthotopic liver transplantation.